Repligen Shares Rise 13% on Higher Second-Quarter Revenue, Full-Year Outlook
By Kathryn Hardison Repligen Corp. shares rose 13% to $239.94 on Tuesday after the life-sciences company said revenue jumped 27% during the second quarter....
The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: editorial@longbridge.global
Like